Triple
T11444972
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Federal Commission for the Protection against Sanitary Risk |
E271239
|
entity |
| Predicate | shortName |
P43
|
FINISHED |
| Object |
COFEPRIS
COFEPRIS is Mexico’s national health regulatory authority responsible for overseeing the safety of medicines, medical devices, food, and other products that pose sanitary risks.
|
E926318
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: COFEPRIS | Statement: [Federal Commission for the Protection against Sanitary Risk, shortName, COFEPRIS]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: COFEPRIS Context triple: [Federal Commission for the Protection against Sanitary Risk, shortName, COFEPRIS]
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
Federal Service for State Registration of Medicines
The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
center for pharmaceutical research in the Philippines
The center for pharmaceutical research in the Philippines is a leading national hub for drug discovery, development, and academic training in pharmacy and pharmaceutical sciences.
-
E.
Pharmaceuticals and Medical Devices Agency Japan
The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: COFEPRIS Triple: [Federal Commission for the Protection against Sanitary Risk, shortName, COFEPRIS]
Generated description
COFEPRIS is Mexico’s national health regulatory authority responsible for overseeing the safety of medicines, medical devices, food, and other products that pose sanitary risks.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: COFEPRIS Target entity description: COFEPRIS is Mexico’s national health regulatory authority responsible for overseeing the safety of medicines, medical devices, food, and other products that pose sanitary risks.
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
Federal Service for State Registration of Medicines
The Federal Service for State Registration of Medicines is a Russian government agency responsible for evaluating, approving, and overseeing the circulation of pharmaceutical drugs within the country.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
center for pharmaceutical research in the Philippines
The center for pharmaceutical research in the Philippines is a leading national hub for drug discovery, development, and academic training in pharmacy and pharmaceutical sciences.
-
E.
Pharmaceuticals and Medical Devices Agency Japan
The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aadff8888190a13f253f0d460874 |
completed | April 8, 2026, 7:22 p.m. |
| NER | Named-entity recognition | batch_69d8088a66f48190b2b4a56cd62097cf |
completed | April 9, 2026, 8:14 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69e5d3afe7fc8190acc8c803ff5efe5a |
completed | April 20, 2026, 7:20 a.m. |
| NEDg | Description generation | batch_69e5d5cac9108190b7756329bfa320d3 |
completed | April 20, 2026, 7:29 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69e5d7fd235081909870476cbc9817b2 |
completed | April 20, 2026, 7:38 a.m. |
Created at: April 8, 2026, 9:35 p.m.